ASCO GU 2025: CLARIFY: PET Using 64Cu-SAR-bisPSMA in Patients with High-Risk Prostate Cancer Prior to Radical Prostatectomy—A Phase 3 Diagnostic Performance Study
https://www.urotoday.com/conference-highlights/asco-gu-2025/asco-gu-2025-prostate-cancer/158214-asco-gu-2025-cobra-assessment-of-the-efficacy-of-64cu-sar-bispsma-using-histopathology-as-reference-standard-in-patients-with-biochemical-recurrence-of-prostate-cancer-following-definitive-therapy.html
ASCO GU 2025: CLARIFY: PET Using 64Cu-SAR-bisPSMA in Patients...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.37 |
Change
0.040(0.92%) |
Mkt cap ! $1.413B | |||
| Open | High | Low | Value | Volume |
| $4.41 | $4.57 | $4.32 | $15.13M | 3.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8635 | $4.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.41 | 24128 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |